XOMA Royalty Corporation (XOMA)
(Delayed Data from NSDQ)
$36.70 USD
-0.89 (-2.37%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $36.48 -0.22 (-0.60%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
XOMA 36.70 -0.89(-2.37%)
Will XOMA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for XOMA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for XOMA
Does XOMA Royalty (XOMA) Have the Potential to Rally 85.34% as Wall Street Analysts Expect?
Wall Street Analysts Predict an 86.05% Upside in XOMA Royalty (XOMA): Here's What You Should Know
XOMA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why XOMA Royalty (XOMA) Is a Great 'Buy the Bottom' Stock Now
How Much Upside is Left in XOMA Royalty (XOMA)? Wall Street Analysts Think 106.15%
XOMA Royalty (XOMA) Q2 Earnings and Revenues Surpass Estimates
Other News for XOMA
Is XOMA positioned for a breakout? Slingshot Bullish shows up after sinking 2.37%
Pocket Pivot appears for XOMA after 2.31% move
1,2,3 Pullback Bullish appears for XOMA after 0.94% move
Xoma announces closing of tender offer for HilleVax
Xoma announces closing of tender offer for HilleVax